Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Müller, SA; Mehrabi, A; Rahbari, NN; Warschkow, R; Elbers, H; Leowardi, C; Fonouni, H; Tarantino, I; Schemmer, P; Schmied, BM; Büchler, MW.
Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.
Ann Surg Oncol. 2014; 21(1):155-164
Doi: 10.1245/s10434-013-3226-9
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Schemmer Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- To assess the impact of perioperative blood transfusion on overall and disease-free survival in patients undergoing curative resection for cholangiocarcinoma. In a single-center study, 128 patients undergoing curative resection for cholangiocarcinoma between 2001 and 2010 were assessed. The median follow-up period was 19 months. Transfused and nontransfused patients were compared by Cox regression and propensity score analyses. Overall, 38 patients (29.7 %) received blood transfusions. The patient characteristics were highly biased with respect to receiving transfusions (propensity score 0.69 ± 0.22 vs. 0.11 ± 0.16, p < 0.001). In the unadjusted analysis, blood transfusion was associated with a 105 % increased risk of mortality [hazard ratio (HR) 2.05, 95 % CI 1.19-3.51, p = 0.010]. In the multivariate (HR 1.14, 95 % CI 0.52-2.48, p = 0.745) and the propensity score-adjusted Cox regression (HR 1.02, 95 % CI 0.39-2.62, p = 0.974), blood transfusion had no influence on overall survival. Similarly, in the propensity score-adjusted Cox regression (HR 0.62, 95 % CI 0.24-1.58, p = 0.295), no relevant effect of blood transfusion on disease-free survival was observed. To our knowledge, this is the first propensity score-based analysis providing compelling evidence that the worse oncological outcome after curative resection for advanced cholangiocarcinoma in patients receiving perioperative blood transfusions is caused by the clinical circumstances requiring the transfusions, not by the blood transfusions themselves.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Bile Duct Neoplasms - mortality
- Bile Duct Neoplasms - pathology
- Bile Duct Neoplasms - therapy
- Bile Ducts, Intrahepatic -
- Blood Transfusion -
- Cholangiocarcinoma - mortality
- Cholangiocarcinoma - pathology
- Cholangiocarcinoma - therapy
- Combined Modality Therapy -
- Disease-Free Survival -
- Female -
- Follow-Up Studies -
- Hepatectomy -
- Humans -
- Male -
- Middle Aged -
- Neoplasm Staging -
- Perioperative Care -
- Prognosis -
- Retrospective Studies -
- Survival Rate -
- Transplantation, Homologous -